Who are Amplifyer Bio's investors?

Amplifyer Bio's investors include Pillar VC.

How much funding has Amplifyer Bio raised?

Amplifyer Bio has disclosed $7.1M raised across 1 round.

Where is Amplifyer Bio headquartered?

Amplifyer Bio is headquartered in Lexington, US.

Amplifyer Bio

Lexington, US · Founded 2023 · Delaware corporation · 10 employees on LinkedIn · 1 known investors

Find your way into Amplifyer Bio

479 people in our graph share verified history with the Amplifyer Bio team — schools, employers, funds. One of them is your warm intro.

Anika Guptaunlockedknows Annie Murphy · together at Foundation Medicine (overlapped)

×2knows the team · via Boston College

×7knows the team · via University of California, Berkeley

knows the team · via Citi

knows the team · via Foundation Medicine

Amplifyer develops liquid biopsy technology aimed at improving outcomes for cancer patients. The company operates in the biotech and diagnostics space.

Biotech Healthtech Medical Devices

Founders & leadership

Annie Murphy inChief Executive OfficerAnnie Murphy leads Amplifyer Bio, which develops liquid biopsy technology for cancer patients. She has background in product strategy, regulatory approval, and commercialization across diagnostic and therapeutic sectors, with early career experience in leveraged finance.

Eric K. HuangNamed on SEC filing

J. Christopher LoveNamed on SEC filing

Viktor A. AdalsteinssonNamed on SEC filing

Board

Thomas de Vlaam in 𝕏Board directorPartner at Pillar VC

Stanley Lapidus inBoard member, Founding AdvisorCEO, SynapDX & Founding Pillar at Pillar VC

Investors · 1

Pillar VCBoston · $50K – $4M

Reported raises · per SEC filings

Form D private placements

$7.1M disclosed across 1 round · 2024

▶$7.1MraisedOct 2024 · 12 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Eric K. HuangExecutive Officer, Director
J. Christopher LoveDirector
Thomas de VlaamDirector
Viktor A. AdalsteinssonDirector
Stanley LapidusDirector

Offering amount: $7.1M
Amount sold: $7.1M
First sale: Sep 2024
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Amplifyer Bio do?: Amplifyer develops liquid biopsy technology aimed at improving outcomes for cancer patients. The company operates in the biotech and diagnostics space.
Who are Amplifyer Bio's investors?: Amplifyer Bio's investors include Pillar VC.
How much funding has Amplifyer Bio raised?: Amplifyer Bio has disclosed $7.1M raised across 1 round.
Where is Amplifyer Bio headquartered?: Amplifyer Bio is headquartered in Lexington, US.